In the global medical devices industry, there were 122 M&A deals announced in Q2 2024, worth a total value of $21.1bn, according to GlobalData’s Deals Database. The $13.1bn acquisition of Shockwave Medical by Johnson & Johnson was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in Q2 2024 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
Smarter leaders trust GlobalData
In value terms, M&A activity increased by 197% in Q2 2024 compared with the previous quarter’s total of $7.1bn and rose by 275% as compared to Q2 2023. Related deal volume decreased by 5% in Q2 2024 versus the previous quarter and was 19% lower than in Q2 2023.
Notably, foreign direct investments (fdi)-related deals accounted for a 38% share of the global medical devices industry’s M&A activity in Q2 2024, up 6% over the previous quarter.
The top-ranked financial advisors supporting these M&A deals in H1 2024 were Jefferies Financial Group; Stifel Financial; Houlihan Lokey with 5, 3, 2 deals respectively.
The top-ranked legal advisors supporting these M&A deals in H1 2024 were Kirkland & Ellis; CMS Legal Services EEIG; Ropes & Gray with 6, 5, 4 deals respectively.
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In Q2 2024 – Thematic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Deals Database tracks global deal activity, including mergers, acquisitions, capital raising, strategic alliances, and licensing agreements. Proprietary analysis is used to group deals into key thematic areas and granular sectors across the world’s largest industries.
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Deal type includes Acquisition, Asset transactions and Mergers.
